{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:02:02Z","timestamp":1793581322757,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-09227-0","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:24:14Z","timestamp":1751415854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Computed tomography guided high dose rate brachytherapy for induced oligoprogression of colorectal cancer liver metastases"],"prefix":"10.1038","volume":"15","author":[{"given":"Pawe\u0142","family":"Cisek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Kuncman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Alicja","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Wojtyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Orzechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Sroka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Kordzi\u0144ska-Cisek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Fijuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Bilski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"9227_CR1","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1200\/JCO.2009.23.4450","volume":"28","author":"SL Wong","year":"2010","unstructured":"Wong, S. L. et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 28, 493\u2013508 (2010).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"9227_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/annonc\/mdv037","volume":"26","author":"T de Ba\u00e8re","year":"2015","unstructured":"de Ba\u00e8re, T. et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 26, 987\u2013991 (2015).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"9227_CR3","doi-asserted-by":"publisher","first-page":"800920","DOI":"10.3389\/fonc.2022.800920","volume":"12","author":"E Karagiannis","year":"2022","unstructured":"Karagiannis, E. et al. Narrative review of high-dose-rate interstitial brachytherapy in primary or secondary liver tumors. Front. Oncol. 12, 800920 (2022).","journal-title":"Front. Oncol."},{"key":"9227_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3390\/cancers16010142","volume":"16","author":"R Yokoi","year":"2024","unstructured":"Yokoi, R. et al. Optimizing treatment strategy for oligometastases\/oligo-recurrence of colorectal cancer. Cancers 16, 142 (2024).","journal-title":"Cancers"},{"key":"9227_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijrobp.2022.06.067","volume":"114","author":"D Nevens","year":"2022","unstructured":"Nevens, D. et al. Completeness of reporting oligometastatic disease characteristics in the literature and influence on oligometastatic disease classification using the ESTRO\/EORTC nomenclature. Int. J. Radiat. Oncol. Biol. Phys. 114, 587\u2013595 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"9227_CR6","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger, M. et al. Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. Lancet Oncol. 21, e18\u2013e28 (2020).","journal-title":"Lancet Oncol."},{"key":"9227_CR7","first-page":"100815","volume":"48","author":"M Bilski","year":"2024","unstructured":"Bilski, M. et al. HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases - A dosimetric comparison study of three radioablative techniques. Clin. Transl. Radiat. Oncol. 48, 100815 (2024).","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"9227_CR8","first-page":"75","volume":"12","author":"P Cisek","year":"2017","unstructured":"Cisek, P. et al. Biochemical liver function markers after CT-guided brachytherapy for liver metastases. Age 12, 75 (2017).","journal-title":"Age"},{"key":"9227_CR9","doi-asserted-by":"publisher","first-page":"1478872","DOI":"10.3389\/fonc.2024.1478872","volume":"14","author":"ME Bilski","year":"2024","unstructured":"Bilski, M. E. et al. Radiotherapy as a metastasis directed therapy (MDT) for liver oligometastases -comparative analysis between CT-guided interstitial HDR brachytherapy and two SBRT modalities performed on double-layer and single layer LINACs. Front. Oncol. 14, 1478872 (2024).","journal-title":"Front. Oncol."},{"key":"9227_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335, 806 (2007).","journal-title":"BMJ"},{"key":"9227_CR11","doi-asserted-by":"publisher","first-page":"20160251","DOI":"10.1259\/bjr.20160251","volume":"89","author":"P Cheung","year":"2016","unstructured":"Cheung, P. Stereotactic body radiotherapy for oligoprogressive cancer. Br. J. Radiol. 89, 20160251 (2016).","journal-title":"Br. J. Radiol."},{"key":"9227_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3857\/roj.2017.00024","volume":"35","author":"YJ Cha","year":"2017","unstructured":"Cha, Y. J. et al. Stereotactic body radiation therapy for liver oligo-recurrence and oligo-progression from various tumors. Radiat. Oncol. J. 35, 172\u2013179 (2017).","journal-title":"Radiat. Oncol. J."},{"key":"9227_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lungcan.2015.04.009","volume":"89","author":"KD Westover","year":"2015","unstructured":"Westover, K. D. et al. SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer. Lung Cancer Amst. Neth. 89, 87\u201393 (2015).","journal-title":"Lung Cancer Amst. Neth."},{"key":"9227_CR14","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.18632\/oncotarget.3455","volume":"6","author":"DK Reyes","year":"2015","unstructured":"Reyes, D. K. & Pienta, K. J. The biology and treatment of oligometastatic cancer. Oncotarget 6, 8491\u20138524 (2015).","journal-title":"Oncotarget"},{"key":"9227_CR15","doi-asserted-by":"publisher","first-page":"djx015","DOI":"10.1093\/jnci\/djx015","volume":"109","author":"T Ruers","year":"2017","unstructured":"Ruers, T. et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. JNCI J. Natl. Cancer Inst. 109, djx015 (2017).","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"9227_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.radonc.2018.10.024","volume":"133","author":"C Franzese","year":"2019","unstructured":"Franzese, C. et al. Predictive factors for survival of oligometastatic colorectal cancer treated with stereotactic body radiation therapy. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 133, 220\u2013226 (2019).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"9227_CR17","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.3748\/wjg.v20.i20.6113","volume":"20","author":"\u00d6 Akg\u00fcl","year":"2014","unstructured":"Akg\u00fcl, \u00d6. et al. Role of surgery in colorectal cancer liver metastases. World J. Gastroenterol. 20, 6113\u20136122 (2014).","journal-title":"World J. Gastroenterol."},{"key":"9227_CR18","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.3748\/wjg.v20.i20.6133","volume":"20","author":"HK Kim","year":"2014","unstructured":"Kim, H. K. et al. Pulmonary metastasectomy for colorectal cancer: how many nodules, how many times?. World J. Gastroenterol. 20, 6133\u20136145 (2014).","journal-title":"World J. Gastroenterol."},{"key":"9227_CR19","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","volume":"27","author":"KE Rusthoven","year":"2009","unstructured":"Rusthoven, K. E. et al. Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 27, 1572\u20131578 (2009).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"9227_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/bjs.6895","volume":"97","author":"AEM van der Pool","year":"2010","unstructured":"van der Pool, A. E. M. et al. Stereotactic body radiation therapy for colorectal liver metastases. Br. J. Surg. 97, 377\u2013382 (2010).","journal-title":"Br. J. Surg."},{"key":"9227_CR21","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","volume":"27","author":"MT Lee","year":"2009","unstructured":"Lee, M. T. et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J. Clin. Oncol. 27, 1585\u20131591 (2009).","journal-title":"J. Clin. Oncol."},{"key":"9227_CR22","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.radonc.2018.06.035","volume":"129","author":"F Petrelli","year":"2018","unstructured":"Petrelli, F. et al. SBRT for CRC liver metastases. Stereotactic body radiotherapy for colorectal cancer liver metastases: A systematic review. Radiother. Oncol. 129, 427\u2013434 (2018).","journal-title":"Radiother. Oncol."},{"key":"9227_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11604-022-01335-5","volume":"40","author":"K Tomita","year":"2022","unstructured":"Tomita, K. et al. Evidence on percutaneous radiofrequency and microwave ablation for liver metastases over the last decade. Jpn. J. Radiol. 40, 1035\u20131045. https:\/\/doi.org\/10.1007\/s11604-022-01335-5 (2022).","journal-title":"Jpn. J. Radiol."},{"key":"9227_CR24","first-page":"8717","volume":"15","author":"D Kieszko","year":"2018","unstructured":"Kieszko, D. et al. Treatment of hepatic metastases with computed tomography-guided interstitial brachytherapy. Oncol. Lett. 15, 8717\u20138722 (2018).","journal-title":"Oncol. Lett."},{"key":"9227_CR25","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ijrobp.2009.09.026","volume":"78","author":"J Ricke","year":"2010","unstructured":"Ricke, J. et al. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 78, 479\u2013485 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"9227_CR26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1055\/s-0033-1355887","volume":"186","author":"F Collettini","year":"2014","unstructured":"Collettini, F. et al. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT). ROFO Fortschr. Geb. Rontgenstr. Nuklearmed. 186, 606\u2013612 (2014).","journal-title":"ROFO Fortschr. Geb. Rontgenstr. Nuklearmed."},{"key":"9227_CR27","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.3390\/cancers13246250","volume":"13","author":"F Walter","year":"2021","unstructured":"Walter, F. et al. Interstitial high-dose-rate brachytherapy of liver metastases in oligometastatic patients. Cancers 13, 6250 (2021).","journal-title":"Cancers"},{"key":"9227_CR28","doi-asserted-by":"publisher","first-page":"204062232311973","DOI":"10.1177\/20406223231197311","volume":"14","author":"T Deng","year":"2023","unstructured":"Deng, T. et al. Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study. Ther. Adv. Chronic Dis. 14, 20406223231197310 (2023).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"9227_CR29","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","volume":"372","author":"RJ Mayer","year":"2015","unstructured":"Mayer, R. J. et al. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N. Engl. J. Med. 372, 1909\u20131919 (2015).","journal-title":"N. Engl. J. Med."},{"key":"9227_CR30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/cancers16010126","volume":"16","author":"LS Tarpgaard","year":"2023","unstructured":"Tarpgaard, L. S., Winther, S. B. & Pfeiffer, P. Treatment options in late-line colorectal cancer: Lessons learned from recent randomized studies. Cancers 16, 126 (2023).","journal-title":"Cancers"},{"issue":"1","key":"9227_CR31","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.jhepr.2022.100594","volume":"5","author":"CH Rim","year":"2022","unstructured":"Rim, C. H., Lee, J. S., Kim, S. Y. & Seong, J. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis. JHEP Rep. 5(1), 100594 (2022).","journal-title":"JHEP Rep."},{"issue":"8","key":"9227_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/1754-9485.13613","volume":"67","author":"L Crocetti","year":"2023","unstructured":"Crocetti, L., Scalise, P., Bozzi, E., Candita, G. & Cioni, R. Thermal ablation of hepatocellular carcinoma. J. Med. Imaging Radiat. Oncol. 67(8), 817\u2013831 (2023).","journal-title":"J. Med. Imaging Radiat. Oncol."},{"issue":"3","key":"9227_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10585-025-10348-z","volume":"42","author":"P Cisek","year":"2025","unstructured":"Cisek, P. et al. EORTC\/ESTRO defined induced oligopersistence of liver metastases from colorectal cancer - outcomes and toxicity profile of computer tomography guided high-dose-rate brachytherapy. Clin. Exp. Metastasis 42(3), 29 (2025).","journal-title":"Clin. Exp. Metastasis"},{"key":"9227_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-025-01988-y","author":"M Bilski","year":"2025","unstructured":"Bilski, M. et al. Comprehensive cohort study: computer tomography-guided high-dose rate brachytherapy as metastasis-directed therapy for liver metastases from colorectal cancer in repeat oligoprogression. Radiol. Med. https:\/\/doi.org\/10.1007\/s11547-025-01988-y (2025).","journal-title":"Radiol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09227-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09227-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:24:15Z","timestamp":1751415855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-09227-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9227"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-09227-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22735"}}